Tirzepatide has emerged as a groundbreaking treatment for type 2 diabetes, offering promising effects. However, the price of this innovative drug and its supply have become key topics for patients and healthcare practitioners. While tirzepatide has been authorized by regulatory agencies, its costly nature presents a significant barrier to many. Ne